Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Sarepta Therapeutics Inc’s stock clocked out at $124.25, down -1.33% from its previous closing price of $125.92. In other words, the price has decreased by -$1.33 from its previous closing price. On the day, 0.9 million shares were traded. SRPT stock price reached its highest trading level at $127.18 during the session, while it also had its lowest trading level at $124.21.
Ratios:
To gain a deeper understanding of SRPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.19 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.19.
On July 29, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $182.
Citigroup Downgraded its Buy to Neutral on June 26, 2024, whereas the target price for the stock was revised from $172 to $176.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 30 ’24 when Estepan Ian Michael sold 5,985 shares for $137.36 per share. The transaction valued at 822,100 led to the insider holds 33,946 shares of the business.
Estepan Ian Michael bought 5,985 shares of SRPT for $822,130 on Aug 30 ’24. On Aug 16 ’24, another insider, Chambers Michael Andrew, who serves as the Director of the company, bought 37,038 shares for $133.80 each. As a result, the insider paid 4,955,728 and bolstered with 284,034 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRPT now has a Market Capitalization of 11849263104 and an Enterprise Value of 11775837184. As of this moment, Sarepta’s Price-to-Earnings (P/E) ratio for their current fiscal year is 307.17, and their Forward P/E ratio for the next fiscal year is 11.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.87 while its Price-to-Book (P/B) ratio in mrq is 10.99. Its current Enterprise Value per Revenue stands at 7.825 whereas that against EBITDA is 151.458.
Stock Price History:
Over the past 52 weeks, SRPT has reached a high of $173.25, while it has fallen to a 52-week low of $55.25. The 50-Day Moving Average of the stock is -3.66%, while the 200-Day Moving Average is calculated to be -4.06%.
Shares Statistics:
It appears that SRPT traded 966.04K shares on average per day over the past three months and 821410 shares per day over the past ten days. A total of 93.73M shares are outstanding, with a floating share count of 89.52M. Insiders hold about 6.13% of the company’s shares, while institutions hold 92.36% stake in the company. Shares short for SRPT as of 1727654400 were 6188097 with a Short Ratio of 6.41, compared to 1724976000 on 6530777. Therefore, it implies a Short% of Shares Outstanding of 6188097 and a Short% of Float of 6.78.
